182 related articles for article (PubMed ID: 22683941)
1. The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.
Fu C; Bian D; Liu F; Feng X; Du W; Wang X
Int J Gynecol Cancer; 2012 Jul; 22(6):1037-43. PubMed ID: 22683941
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
3. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
6. Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.
Feng Y; Liu H; Ding Y; Zhang Y; Liao C; Jin Y; Ai C
Tumori; 2020 Apr; 106(2):155-164. PubMed ID: 31736439
[TBL] [Abstract][Full Text] [Related]
7. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.
Minig L; Zanagnolo V; Cárdenas-Rebollo JM; Colombo N; Maggioni A
Eur J Surg Oncol; 2016 Sep; 42(9):1372-7. PubMed ID: 27247200
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the early predictive power of quantitative magnetic resonance imaging parameters during neoadjuvant chemotherapy for uterine cervical cancer.
Himoto Y; Fujimoto K; Kido A; Matsumura N; Baba T; Daido S; Kiguchi K; Shitano F; Konishi I; Togashi K
Int J Gynecol Cancer; 2014 May; 24(4):751-7. PubMed ID: 24685827
[TBL] [Abstract][Full Text] [Related]
10. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
12. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
Pinkavova I; Fischerova D; Zikan M; Burgetova A; Slama J; Svarovsky J; Dundr P; Dusek L; Cibula D
Ultrasound Obstet Gynecol; 2013 Dec; 42(6):705-12. PubMed ID: 23495185
[TBL] [Abstract][Full Text] [Related]
13. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of diffusion weighted MR imaging with the prognosis of local advanced gastric carcinoma after neoadjuvant chemotherapy].
Tang L; Sun Y; Li Z; Zhang X; Cao K; Li X; Shan F; Li Z; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):221-6. PubMed ID: 25809323
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
18. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.
Kuang F; Yan Z; Wang J; Rao Z
Magn Reson Imaging; 2014 May; 32(4):342-9. PubMed ID: 24512795
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation.
Liu Y; Bai R; Sun H; Liu H; Zhao X; Li Y
Clin Radiol; 2009 Nov; 64(11):1067-74. PubMed ID: 19822239
[TBL] [Abstract][Full Text] [Related]
20. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
